{"id":1036320,"date":"2012-04-26T08:11:15","date_gmt":"2012-04-26T08:11:15","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/senator-enzi-honored-as-bio-legislator-of-the-year.php"},"modified":"2024-08-17T15:55:30","modified_gmt":"2024-08-17T19:55:30","slug":"senator-enzi-honored-as-bio-legislator-of-the-year","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/senator-enzi-honored-as-bio-legislator-of-the-year.php","title":{"rendered":"Senator Enzi Honored as BIO Legislator of the Year"},"content":{"rendered":"<p><p>      WASHINGTON--(BUSINESS WIRE)--    <\/p>\n<p>      The Biotechnology Industry Organization      (BIO) announced today its selection of Senator Michael Enzi      (R-WY) as a Legislator of the Year for 2011-2012.      Senator      Enzi receives the award in conjunction with todays      BIO Legislative Day Fly-In reception.    <\/p>\n<p>      \"As the ranking minority member of the Committee on Health,      Education, Labor, and Pensions, Senator Enzi has been      instrumental to the growth of the life science industry.      Thanks to his support, American doctors and scientists are      better able to translate innovative research into new cures      and treatments for debilitating diseases, such as multiple      sclerosis and HIV\/AIDS, and provide cutting-edge technologies      to improve crop yields, and discover cleaner forms of      home-grown energy,\" said BIO President and CEO Jim      Greenwood.As a champion of American biotechnology, his      steadfast support for a timely reauthorization of the      Prescription Drug User Fee Act, as well as efforts to ensure      reforms to the Accelerated Approval pathway at the FDA,      reflect a keen understanding of important healthcare issues.    <\/p>\n<p>      More than 200 biotechnology industry      representatives from 41 states will participate in hundreds      of meetings with Members of the House and Senate during the      BIO Legislative Day Fly-In.Participants will discuss      issues critical to the biotechnology industry including      reauthorization of the Prescription Drug User Fee Act, the      Transforming the Regulatory Environment to Accelerate Access      to Treatments (TREAT) Act\/Faster Access to Specialized      Treatments (FAST) Act, adequate reimbursement for vital      therapies under Medicare, and capital formation issues      relevant to biotechnology companies.    <\/p>\n<p>      Photos of the award presentation are available upon      request.    <\/p>\n<p>      BIO represents more than 1,100 biotechnology companies,      academic institutions, state biotechnology centers and      related organizations across the United States and in more      than 30 other nations. BIO members are involved in the      research and development of innovative healthcare,      agricultural, industrial and environmental biotechnology      products. BIO also produces the BIO International Convention,      the worlds largest gathering of the biotechnology industry,      along with industry-leading investor and partnering meetings      held around the world.    <\/p>\n<\/p>\n<p>Visit link:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/senator-enzi-honored-bio-legislator-080000401.html;_ylt=A2KJjb0HA5lPHDQAQQT_wgt.\" title=\"Senator Enzi Honored as BIO Legislator of the Year\" rel=\"noopener\">Senator Enzi Honored as BIO Legislator of the Year<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) announced today its selection of Senator Michael Enzi (R-WY) as a Legislator of the Year for 2011-2012. Senator Enzi receives the award in conjunction with todays BIO Legislative Day Fly-In reception. \"As the ranking minority member of the Committee on Health, Education, Labor, and Pensions, Senator Enzi has been instrumental to the growth of the life science industry <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/senator-enzi-honored-as-bio-legislator-of-the-year.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1036320","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036320"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1036320"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036320\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1036320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1036320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1036320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}